- Protocol Short Name and Number: GVHD Prophylaxis, 0402
- Protocol Long Name: A Phase III Randomized, Multicenter Trial Comparing
Sirolimus/Tacrolimus with Tacrolimus/Methotrexate as GVHD Prophylaxis After HLA-Matched, Related Peripheral Blood Stem Cell Transplantation - Protocol (PDF)
- Consent Forms (PDF)
- Frequently Asked Questions
- Key Personnel
- BMT CTN # 0402 Protocol Co-Chair: Joseph Antin, MD
- BMT CTN # 0402 Protocol Co-Chair: Corey Cutler, MD
- BMT CTN # 0402 Protocol Officer: Marcelo Pasquini, MD
- BMT CTN # 0402 Medical Monitor: Mary Eapen, MD
- BMT CTN # 0402 Protocol Coordinator: bmtctn@emmes.com
- Keywords: Graft versus Host Disease, GVHD, Graft vs. Host Disease, Allogeneic Transplant, Allo Transplant, Allo, Prophylaxis, Pediatric, Leukemia, Myelodysplastic Syndrome, Child, Children, Teen, Adolescent
This study closed to patient accrual on October 28, 2011.